GlassScriptPhysician profile
Rohit Bakshi
NPI 1598722274
$196,200.24
in general payments reported to CMS, 2019-2025
4 companies · $41K in 2025
The $41K reported for 2025 was more than what 96% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28K · 2020: $5,572 · 2021: $31K · 2022: $31K · 2023: $35K · 2024: $24K · 2025: $41K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $81K · Travel and Lodging: $9,918 · Consulting Fee: $6,590 · Food and Beverage: $1,987 · Education: $113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $81,444.00 |
| Travel and Lodging | $9,917.74 |
| Consulting Fee | $6,590.00 |
| Food and Beverage | $1,987.39 |
| Education | $113.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Emd Serono, INC. | $177,587.21 | 2019-2025 | |
| Genzyme Corporation | $14,773.03 | 2023-2025 | |
| E.R. Squibb & Sons, L.L.C. | $3,840.00 | 2021 |
1 company reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rohit Bakshi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.